Join
Live feed
·
PRReleasevia Quantisnow
Paratek Pharmaceuticals Inc. logo

Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue of $40.0 Million

ByQuantisnow·Wall Street's wire, on your screen.
PRTK· Paratek Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.